Life sciences manufacturers face growing regulatory complexity, rising data volumes, and accelerating digital transformation. To stay competitive, organizations must not only meet FDA and EMA GMP requirements but also embrace digital systems that unify maintenance, calibration, inventory, and lifecycle management.
In this webinar, Blue Mountain’s Jinnie Lee and Jennifer Chen share proven strategies for implementing compliant, digital-first enterprise asset management (EAM) across pharma, biotech, medical device, CDMO, and CRO organizations.
Key takeaways include:
-
Enforcing ALCOA data integrity principles in both paper and digital records
-
Selecting and validating EAM systems that meet FDA and EMA global standards
-
Mapping and optimizing SOPs before digital rollout to avoid inefficiencies
-
Understanding regulatory trends around AI, CSA vs. CSV, and Pharma 4.0
-
Building long-term success with phased rollouts, super-user programs, and continuous improvement
Watch the replay to learn how leading life sciences companies are elevating GMP compliance while driving efficiency, audit readiness, and digital maturity.